PeerVoice Endocrinology & Metabolic Disorders Video

Oct 25 2024 51 ep. 29 mins 540

PeerVoice Endocrinology & Metabolic Disorders Video Podcast artwork

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

Science Health & Fitness Education

Copy RSS

Subscribe on Podcast Addict

Angela Fitch, MD, FACP, MFOMA - This Cannot Weight: A Specialist Guide to Weight Management and Obesity Associated With Emotional Eating Behaviours

Oct 25 2024 19 mins

Visit https://www.peervoice.com/VYS860 to view the entire programme with slides. After completing “Angela Fitch, MD, FACP, MFOMA - This Cannot Weight: A Specialist Guide to Weight Management and Obesity Associated With Emotional Eating Behaviours”, participants will be able to: Describe the current patient- and healthcare-associated barriers to accessing obesity management ther

Jonathan Barratt, PhD, FRCP - Redefining Hope: The IgA Nephropathy Journey

Oct 25 2024 20 mins

Visit https://www.peervoice.com/GPM860 to view the entire programme with slides. After completing “Jonathan Barratt, PhD, FRCP - Redefining Hope: The IgA Nephropathy Journey”, participants will be able to: Summarize the patient perspective of disease burden and unmet needs in the management of immunoglobulin A nephropathy (IgAN); Recognize the clinical significance of establish

James Kim, MBBCh, PgDip, MScCH - Optimizing Glycemic Control With GLP-1 Receptor Agonists in Patients With Diabetes and Cardiovascular Risk: Translating the Evidence to Practice

Oct 25 2024 28 mins

Visit https://www.peervoice.com/QPP860 to view the entire programme with slides. After completing “James Kim, MBBCh, PgDip, MScCH - Optimizing Glycemic Control With GLP-1 Receptor Agonists in Patients With Diabetes and Cardiovascular Risk: Translating the Evidence to Practice”, participants will be able to: Apply clinical practice guidelines to optimize early initiation of GLP-

Jill Trinacty, MD, FRCPC, ABOM - Cases in Diabetes Care: How to Improve Outcomes in Patients With Cardiometabolic Diseases With GLP-1 RAs

Jul 10 2024 17 mins

Visit https://www.peervoice.com/CZD860 to view the entire programme with slides. After completing “Jill Trinacty, MD, FRCPC, ABOM - Cases in Diabetes Care: How to Improve Outcomes in Patients With Cardiometabolic Diseases With GLP-1 RAs”, participants will be able to: Identify patients with type 2 diabetes (T2D) and cardiometabolic diseases who may benefit from glucagon-like pe

Ronald M. Goldenberg, MD, FRCPC, FACE - When Less Is More: How Emerging Once-Weekly Insulins May Enhance Patient-Centred Care for Persons With Type 2 Diabetes

Jun 07 2024 52 mins

Visit https://www.peervoice.com/DKG860 to view the entire programme with slides. After completing “Ronald M. Goldenberg, MD, FRCPC, FACE - When Less Is More: How Emerging Once-Weekly Insulins May Enhance Patient-Centred Care for Persons With Type 2 Diabetes”, participants will be able to: Outline the role of basal insulin in people with type 2 diabetes (T2D) who require treatme

Maria Craig, MBBS, PhD, FRACP, MMed(ClinEpid) - Treating T2D in People of Younger Age in This Day and Age: How Would You Manage These Children and Adolescents With T2D?

May 21 2024 47 mins

Visit https://www.peervoice.com/GBR860 to view the entire programme with slides. After completing “Maria Craig, MBBS, PhD, FRACP, MMed(ClinEpid) - Treating T2D in People of Younger Age in This Day and Age: How Would You Manage These Children and Adolescents With T2D?”, participants will be able to: Evaluate the efficacy and safety evidence for recommended interventions to manag

Alice YY Cheng, MD, FRCPC - Addressing Unmet Needs in Patients With T2D and CKD: Stepping Up Care to Improve Cardiorenal Outcomes

May 10 2024 46 mins

Visit https://www.peervoice.com/ETM860 to view the entire programme with slides. After completing “Alice YY Cheng, MD, FRCPC - Addressing Unmet Needs in Patients With T2D and CKD: Stepping Up Care to Improve Cardiorenal Outcomes”, participants will be able to: Outline morbidity and mortality risks for patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) and curr

Alex Abitbol, MDCM, FRCPC - Next Generation Basal Insulins: From Once Daily to Once Weekly Injections

May 10 2024 24 mins

Visit https://www.peervoice.com/JPS860 to view the entire programme with slides. After completing “Alex Abitbol, MDCM, FRCPC - Next Generation Basal Insulins: From Once Daily to Once Weekly Injections”, participants will be able to: Discuss the latest clinical evidence with existing and emerging long-acting basal insulin analogues in the treatment of patients with type 2 diabet

Fatos Pinar Topsever, MD / Jennifer Green, MD - CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes

Mar 28 2024 33 mins

Visit https://www.peervoice.com/QKR860 to view the entire programme with slides. After completing “Fatos Pinar Topsever, MD / Jennifer Green, MD - CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes”, participants will be able to: Use recommended screening tests to identify chronic kidney disease (CKD) in patients w

George Kassianos, CBE, MD (Hons), FRCGP / Gili Regev-Yochay, MD - Current 2024 COVID-19 Vaccination Campaign: The Evidence Supporting the Call to Action

Feb 28 2024 11 mins

Visit https://www.peervoice.com/BSG860 to view the entire programme with slides. After completing “George Kassianos, CBE, MD (Hons), FRCGP / Gili Regev-Yochay, MD - Current 2024 COVID-19 Vaccination Campaign: The Evidence Supporting the Call to Action”, participants will be able to: Summarise the evidence supporting the need for the current 2024 COVID-19 vaccination campaign fo